Split History
ETFs Holding IMUC »    IMUC Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ImmunoCellular Therapeutics is a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of cancers. Co.'s clinical product candidates include: ICT-107, which is a dendritic cell (DC) immunotherapy for the treatment of newly diagnosed glioblastoma multiforme, a lethal type of brain cancer; ICT-140, which is a DC immunotherapy that targets seven tumor-associated antigens expressed on ovarian cancer cells; and ICT-121, which specifically targets CD133, a cancer stem cell marker that is in a variety of solid tumors, including ovarian, pancreatic, and breast cancers. According to our IMUC split history records, IMUC has had 1 split.
IMUC split history picture
IMUC (IMUC) has 1 split in our IMUC split history database. The split for IMUC took place on November 21, 2016. This was a 1 for 40 reverse split, meaning for each 40 shares of IMUC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 25 share position following the split.

When a company such as IMUC conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the IMUC split history from start to finish, an original position size of 1000 shares would have turned into 25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into IMUC shares, starting with a $10,000 purchase of IMUC, presented on a split-history-adjusted basis factoring in the complete IMUC split history. IMUC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/20/2009
End date: 10/16/2018
Start price/share: $45.60
End price/share: $0.05
Dividends collected/share: $0.00
Total return: -99.89%
Average Annual Total Return: -53.13%
Starting investment: $10,000.00
Ending investment: $10.96
Years: 8.99
Date Ratio
11/21/20161 for 40
IMUC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

INCY Split History
INFI Split History
INO Split History
INSY Split History
INVA Split History
IPCI Split History
IRWD Split History
ISRG Split History
ITUS Split History
IVC Split History

Aethlon Medical, Inc. (AEMD)
Aberdeen Standard Physical Gold Shares ETF (SGOL)
Safe-T Group Ltd. (SFET)
NanoViricides, Inc. (NNVC)
Penns Woods Bancorp, Inc. (PWOD)
MoSys, Inc. (MOSY)
TOP Ships Inc. (TOPS)
Interlapse Technologies Corp. (INLA.CA)
SINTX Technologies, Inc. (SINT)
Pluristem Therapeutics Inc. (PSTI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

IMUC Insider Buying

IMUC Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.